FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Hold Opinion On Adss Of Xpeng Inc.

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our target price to USD20 from USD22, implying a 2026 P/S of 1.3x, a 57% discount to global EV peers' 3.0x average, reflecting margin pressure from AI investments and its second-tier market position. We lower 2026 EPADS to CNY0.33 from CNY0.86 and introduce 2027 EPADS at CNY1.00. We project revenue growth moderating to 20.5%-21% p.a. for 2026 and 2027, largely due to increased vehicle deliveries and new model launches, but declining average selling prices from intensifying competition (BYD, Geely), product mix dilution, and lower subsidies will pressure growth. Improved operating leverage and scale efficiency should support our projected modest margin improvement, but rising cost inflation and elevated R&D investment in AI will limit margin expansion potential. While Q4 2025 achieved record 21.3% gross margin and first quarterly profit, we remain cautious on sustaining profitability through 2026 given fragile margins amid an investment upcycle and intensifying EV competition in China.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605